---
title: "Cadrenal Therapeutics CEO, Chairman Quang X. Pham disposes of 7,400 common shares worth $22,422"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291482268.md"
description: "Cadrenal Therapeutics Chairman and CEO Quang X. Pham sold 7,400 common shares on June 29, 2026, at a weighted average price of $3.03, totaling approximately $22,422. Following the transaction, his directly held stake decreased to 98,589 shares. He continues to hold 200,000 shares indirectly through The PVBQ Living Trust."
datetime: "2026-07-02T01:52:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291482268.md)
  - [en](https://longbridge.com/en/news/291482268.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291482268.md)
generator: "portal-rs"
---

# Cadrenal Therapeutics CEO, Chairman Quang X. Pham disposes of 7,400 common shares worth $22,422

-   Cadrenal Therapeutics Chairman and CEO Quang X. Pham sold 7,400 common shares on June 29, 2026 at a weighted average price of $3.03. \* Directly held stake fell to 98,589 shares following the sale. \* He also reported 200,000 shares held indirectly through The PVBQ Living Trust. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cadrenal Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-074557), on July 01, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [CVKD.US](https://longbridge.com/en/quote/CVKD.US.md)

## Related News & Research

- [Cadrenal Therapeutics CEO presents at H.C. Wainwright Global Investment Conference](https://longbridge.com/en/news/297910480.md)
- [Insider Selling: Cadrenal Therapeutics (NASDAQ:CVKD) CEO Sells 7,400 Shares of Stock](https://longbridge.com/en/news/291657721.md)
- [eDreams Odigeo buys back 60,000 shares at average price EUR 5.51 under stabilization program](https://longbridge.com/en/news/297501270.md)
- [Insider Selling: Riskified (NYSE:RSKD) Director Sells $22,590.81 in Stock](https://longbridge.com/en/news/297901364.md)
- [Safilo liquidity contract buys 1.62 million shares in August at avg price EUR 1.91](https://longbridge.com/en/news/297929865.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**